*Submit your email address to receive conference udpates

BioTrinity 2008 Sponsors and Project Partners

Platinum Sponsor

STIMUTRAN-SME stands for Stimulating Transnational SME Interactions and focuses on SME business matching and cooperation in North West Europe (NWE). This project is implemented with the financial contribution from the European Commission, through the INTERREG IIIB NWE program. The 10 STIMUTRAN-SME partners have established a Transnational Matching Centre (TMC) network which provides SMEs with international business cooperation services. Up to 80 international companies will be brought to BioTrinity through the STIMUTRAN programme.

Gold Sponsors

MEPC Milton Park
MEPC is a leading developer of sustainable business communities. It owns more than 12 million sq ft of business space and lets to over 850 occupiers across the country. Milton Park is one of MEPC’s sustainable business communities and is located about 12 miles south of Oxford just off the A34 dual carriageway. Milton Park is a leading biotech cluster in the UK with over 400,000 sq ft of existing laboratory space and plans for significant further expansion - over 50,000 sq ft Innovation Centre and Graduation Space plus and a new Bioscience Campus of 80,000 sq ft.
The exciting mix of start-ups through to world class PLC’s ensures a dynamic and vibrant environment ideal for cutting edge R&D activities. This critical mass of like-minded companies creates a hub for further innovation and collaboration. MEPC Milton Park is committed to providing the property skills and expertise required at all stages of a business’ development.

Silver Sponsors

Merck Sharp & Dohme
Merck & Co., Inc., USA, is a global research-driven pharmaceutical company dedicated to putting patients first. Merck discovers, develops, manufactures, and markets vaccines and medicines in over 20 therapeutic categories directly and through its joint ventures. Our mission is to provide society with superior products and services by developing innovations and solutions that improve the quality of life.
At Merck, our strategy for growth is based on breakthrough research — both internal and external through partnerships — and demonstrating the value of our medicines to patients, payers, and providers. Worldwide sales in 2005 were $22 billion and Merck continues to invest heavily in research and development.

UK Trade & Investment
UK Trade & Investment is a UK government organisation. We help UK companies do business abroad - and we help overseas companies do business in the UK.
The Biotech and Pharmaceutical International Sector Team has sector–specfic specialists waiting to help you in internationalising your business. With over 75 years of accumulated high-end corporate experience behind them. Our specialists have experience in helping BioPharma companies internationally in the markets of Japan, Korea, India and China as well as Europe and the USA.

Genzyme UK
Genzyme UK is part of one of the world's leading biotechnology companies, dedicated to making a major positive impact on the lives of people with serious diseases. Since 1981, the company has grown into a diversified enterprise with more than 8,000 employees in locations spanning the globe and 2005 revenues of $2.7 billion. The company's products and services are focused on rare inherited disorders, kidney disease, orthopaedics, cancer, transplant and immune diseases, and diagnostic testing. In the UK, Genzyme has a long history, beginning with the acquisition of UK-based speciality pharmaceutical firms in 1981. Genzyme is now a significant presence in the UK biotechnology industry, employing around 500 people.

Bronze Sponsors

Finance South East -Biotechnology Finance Advisory Service (BFAS)
The Biotechnology Finance Advisory Service (BFAS South East), managed by Finance South East, provides a fully integrated service of sector-specific advice and signposting to help companies develop their business proposal and access suitable funding.
Companies have access to a dedicated advisor with specialist expertise and experience in the biotechnology and healthcare sectors, who will assist in refining the viability of the business proposition and associated funding and commercial strategies in preparation for seeking finance.
There are two levels of service available and to qualify companies must be small or medium sized biotechnology or healthcare enterprises based in the South East of England and be a core member of SEHTA (South East Health Technologies Alliance).

Fisher Scientific
As a world-leading supplier of laboratory chemicals, consumables and equipment to the scientific community, Fisher Scientific is proud to be a key sponsor of OBN. Fisher Scientific realise that it’s future lies within the bioscience sector and indeed, building relationships with networks such as OBN. Fisher Scientific, therefore, recognises the need to support such important initiatives as BioTrinity. As part of Fisher Scientific’s strategy, it looks to support the members of the OBN community with a wide range of products; specific offers and services designed for scientists and researchers within the bioscience areas. Fisher Scientific is part of the Thermo Fisher Group, the world’s largest manufacturer and supplier of products to the scientific community.

Giles Insurance
Insurance solutions for the lifescience sector
Giles Insurance Brokers Ltd are specialists in the lifescience sector acting for more than 200 clients in the UK and overseas, from university spin-outs to main market listed companies, including companies involved in the research, development and supply of pharmaceutical and medtech products, CROs and related service providers.
We are proud to be sponsors of both OBN and the BIA.

Specialist areas

We offer a range of specialist insurance products and services, including:

• Global clinical trials
• Pharmaceutical and medical product liability
• Bio-medical errors & omissions / professional indemnity
• Medical malpractice
• Intellectual property litigation and protection
• R&D and supply chain protection
• Marine and goods in transit
• Directors & Officers indemnity

Grant Thornton UK LLP
Grant Thornton UK LLP is a leading financial and business adviser with 30 offices nationwide, and more than 25,000 individuals and 15,000 corporate and institutional clients. We are the UK member of Grant Thornton International, one of the world's leading international organisations of independently owned and managed accounting and consulting firms. These firms provide a comprehensive range of business advisory services from around 521 offices in over 113 countries worldwide. Although Grant Thornton International is not a worldwide partnership, the firms share a commitment to providing the same high quality service to their clients wherever they do business.

Helvoet Pharma
Helvoet Pharma is a leading manufacturer of rubber closures and aluminium caps for injectable drugs.
Helvoet Pharma’s product range includes pharmaceutical vial stoppers, diagnostic stoppers and pre-filled syringe components. The Omniflex range of coated stoppers and plungers completes the portfolio. Our pharmaceutical packaging components can be supplied Ready-for-Sterilization and Ready-for-Use.
With 5 rubber manufacturing plants and 4 plants for the production of aluminium seals and flip caps in Europe and the US, the company is a worldwide key supplier to the pharmaceutical, biopharmaceutical, medical device and diagnostic market.
www.helvoetpharma.com
Contact :
Paul Roosen - Marketing Manager
paul.roosen@helvoetpharma.com

Manches LLP

Manches LLP is a leading law firm with offices in Oxford and London. The Firm offers the full range of company and commercial legal services with a particular emphasis on the life science sector. Of the eight specialist pharmaceutical and biotechnology lawyers listed by Legal 500 for the South East England, three are partners at Manches. The firm has the largest specialist group of lawyers in the South East (excluding London). Typical services to clients involve:
• Establishment, seed funding and funding rounds
• Listing or trade sale
• Collaborative research agreements
• Use of project results and background technology
• Setting up spin-outs and joint ventures
• Securing IPR
• In-licensing and out-licensing
• Co-development and co-marketing
• Clinical manufacturing, clinical supply and clinical trials
• Distribution and supply
• Domestic and foreign litigation
• International arbitration
• Human Resources
• Property requirements
• IT infrastructure and acquisition

PharmaVentures
PharmaVentures has proven success in deals and alliances, offering over 15 years of healthcare industry experience gained from working with in excess of 1000 clients in 38 countries, and conducting more than 450 assignments. PharmaVentures offer access to an unrivalled team of industry specialists who can provide bespoke support on a range of projects, from commercial strategy development to opportunity screening and partnering; Access to a unique range of business intelligence tools that offers you a flexible and cost-effective resource to inform your deal making helping you to gain vital strategic insight and intelligence on a range of subjects from intellectual property to negotiation, deal structure and valuation

RDP Associates
RDP Associates Ltd. ("RDP") is an international business, with extensive experience providing financial and technical expertise to companies claiming R&D tax incentives. Since 1987, RDP has assisted a wide range of businesses, both large and small, in virtually every industry with their R&D tax claim. With the introduction of the U.K.'s R&D Tax Relief program in 2000, RDP expanded operations to the U.K. to offer businesses comprehensive service in maximizing their R&D tax claims. RDP's desire to build long term relationships with there clients, along with their proven methodology and experienced staff, results not only in professional and accurate R&D claims, but also claims that ensure all eligible projects and expenditures have been claimed.

SEHTA
The South East Health Technologies Alliance (SEHTA) facilitates the profitable and sustainable growth of companies in South East England’s health technologies sector – biotechnology, diagnostics, medical devices and pharmaceuticals. By identifying global market opportunities and understanding the needs of industry, we can offer leadership, facilitation and signposting. SEHTA’s aim is to support the growth of mid-sized companies in the sector by providing access to business support, networking and collaboration opportunities. We also bridge the gap between our members and policymakers, regulators, the media and the general public in order to improve the environment in which our members operate.

Thomson Scientific
Thomson Scientific combine authoritative information with innovative technologies to enhance their customers' ability to achieve world-class research and business results. Their information solutions assist professionals at every stage of research and development from discovery and analysis, to product development and distribution. Their integrated solutions are used by researchers, information specialists, and professionals in the fields of biotechnology, chemistry, engineering, healthcare, law, financial services, higher education, reference information, corporate training, and assessment

Marketing and Communications Agent

De Facto Communications
De Facto Communications is the consultancy that life science and healthcare companies choose when they are looking for the best in strategic communications. As part of the Bell Pottinger Group, the UK’s largest communications services group, we offer large consultancy reach and real international influence. We’re specialists in life science and healthcare communications, clinical trial marketing and medical education, with an in-depth knowledge of the industry issues affecting your business. Based in London, we operate internationally through our Group offices in Europe and the US to reach the people you really need to influence. Contact us now for an insightful discussion about your communications needs.

Project Partners

bioProcess UK

BioSpectrumAsia

Drug Discovery Today

European Biotech News

London Biotechnology Network

Pharmalicensing
Pharmalicensing is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting in- and out-licensing activities, Pharmalicensing provides partnering services, business development reports, industry news and a jobs source for candidates and employers.
Pharmalicensing is used by over 90,000 users per month and is a division of UTEK Corporation.

Thames Valley Life Sciences Network

Become a BioTrinity 2008 Project Partner

Media Sponsor : PharmaVentures Ltd

Marketing and Communications Agent: De Facto Communications

Project Partners
Stimutran-SME
DiagnOx
Kent Bioscience Network
South East Medical Device Network (SEMDN)
Surrey Enterprise Hub
Thames Valley Life Sciences Network (TVLSN)

Supporting Partners
Biocentury
Drug Discovery Today
European Biotechnology News

Submit your email address to receive conference updates

PROJECT PARTNERS